Identification of CD20 C-Terminal Deletion Mutations Associated with Loss of CD20 Expression in Non-Hodgkin's Lymphoma-Reference-Cited by-同舟云学术

Identification of CD20 C-Terminal Deletion Mutations Associated with Loss of CD20 Expression in Non-Hodgkin's Lymphoma

Published:2009-03-10 Issue:7 Volume:15 Page:2523-2530
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Terui Yasuhito,Mishima Yuji,Sugimura Natsuhiko,Kojima Kiyotsugu,Sakurai Takuma,Mishima Yuko,Kuniyoshi Ryoko,Taniyama Akiko,Yokoyama Masahiro,Sakajiri Sakura,Takeuchi Kengo,Watanabe Chie,Takahashi Shunji,Ito Yoshinori,Hatake Kiyohiko

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NK Cell Degranulation Triggered by Rituximab Identifies Potential Markers of Subpopulations with Enhanced Cytotoxicity toward Malignant B Cells;International Journal of Molecular Sciences;2024-08-18

2. Biomarkers and coptis chinensis activity for rituximab-resistant diffuse large B-cell lymphoma: Combination of bioinformatics analysis, network pharmacology and molecular docking;Technology and Health Care;2024-07-12

3. Development of Monoclonal Antibodies for the Treatment of Lymphoma;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

4. Reversal of resistance to anti-CD20 antibody therapies: Conclusions and future perspectives;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

5. Mechanisms of resistance to anti-CD20 antibodies in lymphoid malignancies;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024